Notably, the failure of aprinocarsen, which specifically targets PKCα, is not surprising, given the anti-growth/tumor-suppressive activity of PKCα in leukemia and colorectal, ovarian and possibly NSCL cancer models. The gene discussed is PRKCA; the disease is cancer.